Monthly injectable contraceptive use by adolescents in Brazil: evaluation of clinical aspects.
Contraception
; 76(1): 45-8, 2007 Jul.
Article
em En
| MEDLINE
| ID: mdl-17586136
ABSTRACT
PURPOSE:
This prospective noncomparative observational study evaluated the clinical symptoms, body weight and blood pressure of 38 adolescents receiving a monthly injectable contraceptive containing estradiol valerate 5 mg and norethisterone 50 mg.METHODS:
The volunteers, aged 16-19 years, were examined monthly during 1 year and asked about the following symptoms at baseline dysmenorrhea, headache, breast tenderness, leg pain and irritability.RESULTS:
There was a constant and gradual decline in each of the above symptoms over time, and there was a statistically significant difference between symptoms reported at the first visit and subsequent appointments. Body weight and blood pressure did not change significantly during the 1-year period. No pregnancies were observed.CONCLUSION:
These findings suggest that monthly injectable contraception with estradiol valerate 5 mg/norethisterone 50 mg represents a highly effective and well-tolerated contraceptive for teens.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Anticoncepcionais Femininos
/
Estradiol
/
Noretindrona
Tipo de estudo:
Observational_studies
Limite:
Adolescent
/
Female
/
Humans
País/Região como assunto:
America do sul
/
Brasil
Idioma:
En
Revista:
Contraception
Ano de publicação:
2007
Tipo de documento:
Article
País de afiliação:
Brasil